Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.
Open | $53.95 |
Close | $52.09 |
Volume / Avg. | 1.36M / 1.46M |
Day Range | $52.08 - $54.54 |
52 Wk Range | 25.98 - 110.25 |
Market Cap | $6.12B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 23.64% |
Days to Cover | 17.5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.
Other companies in Cytokinetics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Sarepta Therapeutics (NASDAQ:SRPT).
Cytokinetics has a consensus price target of $75.10.
The stock price for Cytokinetics (NASDAQ: CYTK) is $52.01 last updated September 23, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Cytokinetics.
Cytokinetics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Cytokinetics.
Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.